Works by Nakajima, Takako Eguchi

Results: 59
    1
    2

    aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
    By:
    • Fujita, Yoshihiko;
    • Taguri, Masataka;
    • Yamazaki, Kentaro;
    • Tsurutani, Junji;
    • Sakai, Kazuko;
    • Tsushima, Takahiro;
    • Nagase, Michitaka;
    • Tamagawa, Hiroshi;
    • Ueda, Shinya;
    • Tamura, Takao;
    • Tsuji, Yasushi;
    • Murata, Kohei;
    • Taira, Koichi;
    • Denda, Tadamichi;
    • Moriwaki, Toshikazu;
    • Funai, Sadao;
    • Nakajima, Takako Eguchi;
    • Muro, Kei;
    • Tsuji, Akihito;
    • Yoshida, Motoki
    Publication type:
    Article
    3

    Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.

    Published in:
    Cancer Science, 2019, v. 110, n. 11, p. 3565, doi. 10.1111/cas.14198
    By:
    • Hamaguchi, Tetsuya;
    • Denda, Tadamichi;
    • Kudo, Toshihiro;
    • Sugimoto, Naotoshi;
    • Ura, Takashi;
    • Yamazaki, Kentaro;
    • Fujii, Hirofumi;
    • Kajiwara, Takeshi;
    • Nakajima, Takako Eguchi;
    • Takahashi, Shin;
    • Otsu, Satoshi;
    • Komatsu, Yoshito;
    • Nagashima, Fumio;
    • Moriwaki, Toshikazu;
    • Esaki, Taito;
    • Sato, Takeo;
    • Itabashi, Michio;
    • Oki, Eiji;
    • Sasaki, Toru;
    • Chiron, Marielle
    Publication type:
    Article
    4

    Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer.

    Published in:
    Cancer Science, 2019, v. 110, n. 3, p. 1032, doi. 10.1111/cas.13943
    By:
    • Denda, Tadamichi;
    • Sakai, Daisuke;
    • Hamaguchi, Tetsuya;
    • Sugimoto, Naotoshi;
    • Ura, Takashi;
    • Yamazaki, Kentaro;
    • Fujii, Hirofumi;
    • Kajiwara, Takeshi;
    • Nakajima, Takako Eguchi;
    • Takahashi, Shin;
    • Otsu, Satoshi;
    • Komatsu, Yoshito;
    • Nagashima, Fumio;
    • Moriwaki, Toshikazu;
    • Esaki, Taito;
    • Sato, Takeo;
    • Itabashi, Michio;
    • Oki, Eiji;
    • Sasaki, Toru;
    • Sunaga, Yoshinori
    Publication type:
    Article
    5
    6
    7

    Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2021, v. 28, n. 1, p. 1, doi. 10.1002/jhbp.868
    By:
    • Yamamoto, Masakazu;
    • Yoshida, Masahiro;
    • Furuse, Junji;
    • Sano, Keiji;
    • Ohtsuka, Masayuki;
    • Yamashita, Shingo;
    • Beppu, Toru;
    • Iwashita, Yukio;
    • Wada, Keita;
    • Nakajima, Takako Eguchi;
    • Sakamoto, Katsunori;
    • Hayano, Koichi;
    • Mori, Yasuhisa;
    • Asai, Koji;
    • Matsuyama, Ryusei;
    • Hirashita, Teijiro;
    • Hibi, Taizo;
    • Sakai, Nozomu;
    • Tabata, Tsutomu;
    • Kawakami, Hisato
    Publication type:
    Article
    8

    Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment.

    Published in:
    Nutrition & Cancer, 2022, v. 74, n. 2, p. 539, doi. 10.1080/01635581.2021.1902542
    By:
    • Mizukami, Takuro;
    • Hamaji, Koki;
    • Onuki, Risa;
    • Yokomizo, Ayako;
    • Nagashima, Yoshie;
    • Takeda, Hiroyuki;
    • Umemoto, Kumiko;
    • Doi, Ayako;
    • Arai, Hiroyuki;
    • Hirakawa, Mami;
    • Horie, Yoshiki;
    • Izawa, Naoki;
    • Ogura, Takashi;
    • Tsuda, Takashi;
    • Sunakawa, Yu;
    • Shibata, Michi;
    • Tanaka, Tsuneaki;
    • Mikami, Shinya;
    • Nakajima, Takako Eguchi
    Publication type:
    Article
    9
    10
    11

    Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 1, p. 59, doi. 10.1007/s11523-023-01027-8
    By:
    • Sunakawa, Yu;
    • Kuboki, Yasutoshi;
    • Watanabe, Jun;
    • Terazawa, Tetsuji;
    • Kawakami, Hisato;
    • Yokota, Mitsuru;
    • Nakamura, Masato;
    • Kotaka, Masahito;
    • Sugimoto, Naotoshi;
    • Ojima, Hitoshi;
    • Oki, Eiji;
    • Kajiwara, Takeshi;
    • Yamamoto, Yoshiyuki;
    • Tsuji, Yasushi;
    • Denda, Tadamichi;
    • Tamura, Takao;
    • Ishihara, Soichiro;
    • Taniguchi, Hiroya;
    • Nakajima, Takako Eguchi;
    • Morita, Satoshi
    Publication type:
    Article
    12

    Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy.

    Published in:
    Targeted Oncology, 2022, v. 17, n. 3, p. 343, doi. 10.1007/s11523-022-00880-3
    By:
    • Mizukami, Takuro;
    • Takahashi, Masaki;
    • Sunakawa, Yu;
    • Yuki, Satoshi;
    • Kagawa, Yoshinori;
    • Takashima, Atsuo;
    • Kato, Kyoko;
    • Hara, Hiroki;
    • Denda, Tadamichi;
    • Yamamoto, Yoshiyuki;
    • Shiozawa, Manabu;
    • Oki, Eiji;
    • Okamoto, Wataru;
    • Yoshino, Takayuki;
    • Eguchi Nakajima, Takako
    Publication type:
    Article
    13

    Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)

    Published in:
    Targeted Oncology, 2020, v. 15, n. 5, p. 623, doi. 10.1007/s11523-020-00750-w
    By:
    • Izawa, Naoki;
    • Shitara, Kohei;
    • Yonesaka, Kimio;
    • Yamanaka, Takeharu;
    • Yoshino, Takayuki;
    • Sunakawa, Yu;
    • Masuishi, Toshiki;
    • Denda, Tadamichi;
    • Yamazaki, Kentaro;
    • Moriwaki, Toshikazu;
    • Okuda, Hiroyuki;
    • Kondoh, Chihiro;
    • Nishina, Tomohiro;
    • Makiyama, Akitaka;
    • Baba, Hideo;
    • Yamaguchi, Hironori;
    • Nakamura, Masato;
    • Hyodo, Ichinosuke;
    • Muro, Kei;
    • Nakajima, Takako Eguchi
    Publication type:
    Article
    14
    15
    16

    Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 1, doi. 10.1007/s10147-019-01485-z
    By:
    • Hashiguchi, Yojiro;
    • Muro, Kei;
    • Saito, Yutaka;
    • Ito, Yoshinori;
    • Ajioka, Yoichi;
    • Hamaguchi, Tetsuya;
    • Hasegawa, Kiyoshi;
    • Hotta, Kinichi;
    • Ishida, Hideyuki;
    • Ishiguro, Megumi;
    • Ishihara, Soichiro;
    • Kanemitsu, Yukihide;
    • Kinugasa, Yusuke;
    • Murofushi, Keiko;
    • Nakajima, Takako Eguchi;
    • Oka, Shiro;
    • Tanaka, Toshiaki;
    • Taniguchi, Hiroya;
    • Tsuji, Akihito;
    • Uehara, Keisuke
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID).

    Published in:
    Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7107
    By:
    • Arai, Hiroyuki;
    • Tsuda, Takashi;
    • Sunakawa, Yu;
    • Shimokawa, Mototsugu;
    • Akiyoshi, Kohei;
    • Tokunaga, Shinya;
    • Shoji, Hirokazu;
    • Kunieda, Kenji;
    • Kotaka, Masahito;
    • Matsumoto, Toshihiko;
    • Nagata, Yusuke;
    • Mizukami, Takuro;
    • Mizuki, Fumitaka;
    • Danenberg, Kathleen D.;
    • Boku, Narikazu;
    • Nakajima, Takako Eguchi
    Publication type:
    Article
    28

    Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).

    Published in:
    2021
    By:
    • Maruki, Yuta;
    • Morizane, Chigusa;
    • Arai, Yasuhito;
    • Ikeda, Masafumi;
    • Ueno, Makoto;
    • Ioka, Tatsuya;
    • Naganuma, Atsushi;
    • Furukawa, Masayuki;
    • Mizuno, Nobumasa;
    • Uwagawa, Tadashi;
    • Takahara, Naminatsu;
    • Kanai, Masashi;
    • Asagi, Akinori;
    • Shimizu, Satoshi;
    • Miyamoto, Atsushi;
    • Yukisawa, Seigo;
    • Kadokura, Makoto;
    • Kojima, Yasushi;
    • Furuse, Junji;
    • Nakajima, Takako Eguchi
    Publication type:
    corrected article
    29

    Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).

    Published in:
    Journal of Gastroenterology, 2021, v. 56, n. 3, p. 250, doi. 10.1007/s00535-020-01735-2
    By:
    • Maruki, Yuta;
    • Morizane, Chigusa;
    • Arai, Yasuhito;
    • Ikeda, Masafumi;
    • Ueno, Makoto;
    • Ioka, Tatsuya;
    • Naganuma, Atsushi;
    • Furukawa, Masayuki;
    • Mizuno, Nobumasa;
    • Uwagawa, Tadashi;
    • Takahara, Naminatsu;
    • Kanai, Masashi;
    • Asagi, Akinori;
    • Shimizu, Satoshi;
    • Miyamoto, Atsushi;
    • Yukisawa, Seigo;
    • Kadokura, Makoto;
    • Kojima, Yasushi;
    • Furuse, Junji;
    • Nakajima, Takako Eguchi
    Publication type:
    Article
    30

    Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.

    Published in:
    International Journal of Cancer, 2008, v. 122, n. 9, p. 2148, doi. 10.1002/ijc.23381
    By:
    • Nakajima, Takako Eguchi;
    • Yasunaga, Masahiro;
    • Kano, Yasuhiko;
    • Koizumi, Fumiaki;
    • Kato, Ken;
    • Hamaguchi, Tetsuya;
    • Yamada, Yasuhide;
    • Shirao, Kuniaki;
    • Shimada, Yasuhiro;
    • Matsumura, Yasuhiro
    Publication type:
    Article
    31

    A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 199, doi. 10.1093/jjco/hyaa190
    By:
    • Katada, Chikatoshi;
    • Sugawara, Mitsuhiro;
    • Hara, Hiroki;
    • Fujii, Hirofumi;
    • Nakajima, Takako Eguchi;
    • Ando, Takayuki;
    • Kojima, Takashi;
    • Watanabe, Akinori;
    • Sakamoto, Yasutoshi;
    • Ishikawa, Hideki;
    • Hosokawa, Ayumu;
    • Hamamoto, Yasuo;
    • Muto, Manabu;
    • Tahara, Makoto;
    • Koizumi, Wasaburo
    Publication type:
    Article
    32
    33
    34
    35

    Multicenter Feasibility Study of Combination Therapy with Fluorouracil, Leucovorin and Paclitaxel (FLTAX) for Peritoneal Disseminated Gastric Cancer with Massive Ascites or Inadequate Oral Intake.

    Published in:
    Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 787, doi. 10.1093/jjco/hys111
    By:
    • Iwasa, Satoru;
    • Goto, Masahiro;
    • Yasui, Hirofumi;
    • Nishina, Tomohiro;
    • Takahari, Daisuke;
    • Nakayama, Norisuke;
    • Taira, Koichi;
    • Kusaba, Hitoshi;
    • Fuse, Nozomu;
    • Hironaka, Shuichi;
    • Shimada, Yasuhiro;
    • Nakajima, Takako Eguchi
    Publication type:
    Article
    36
    37
    38

    Reply to L. Celio et al.

    Published in:
    2024
    By:
    • Minatogawa, Hiroko;
    • Izawa, Naoki;
    • Nakajima, Takako Eguchi
    Publication type:
    Letter
    39

    Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 10, p. 1897, doi. 10.1038/s41416-023-02212-2
    By:
    • Kuboki, Yasutoshi;
    • Terazawa, Tetsuji;
    • Masuishi, Toshiki;
    • Nakamura, Masato;
    • Watanabe, Jun;
    • Ojima, Hitoshi;
    • Makiyama, Akitaka;
    • Kotaka, Masahito;
    • Hara, Hiroki;
    • Kagawa, Yoshinori;
    • Sugimoto, Naotoshi;
    • Kawakami, Hisato;
    • Takashima, Atsuo;
    • Kajiwara, Takeshi;
    • Oki, Eiji;
    • Sunakawa, Yu;
    • Ishihara, Soichiro;
    • Taniguchi, Hiroya;
    • Nakajima, Takako Eguchi;
    • Morita, Satoshi
    Publication type:
    Article
    40

    Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.

    Published in:
    Molecular Carcinogenesis, 2017, v. 56, n. 1, p. 106, doi. 10.1002/mc.22476
    By:
    • Mizukami, Takuro;
    • Togashi, Yosuke;
    • Naruki, Saeko;
    • Banno, Eri;
    • Terashima, Masato;
    • de Velasco, Marco A.;
    • Sakai, Kazuko;
    • Yoneshige, Azusa;
    • Hayashi, Hidetoshi;
    • Fujita, Yoshihiko;
    • Tomida, Shuta;
    • Nakajima, Takako Eguchi;
    • Fujino, Takashi;
    • Boku, Narikazu;
    • Ito, Akihiko;
    • Nakagawa, Kazuhiko;
    • Nishio, Kazuto
    Publication type:
    Article
    41

    Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

    Published in:
    2025
    By:
    • Nakashima, Kazuhisa;
    • Harashima, Saki;
    • Kaneko, Rena;
    • Tanaka, Ryuhei;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    42

    Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8
    By:
    • Nakashima, Kazuhisa;
    • Yokomizo, Ayako;
    • Murakami, Michiyasu;
    • Okita, Kenji;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi
    Publication type:
    Article
    43

    Out-of-pocket fertility preservation expenses: data from a Japanese nationwide multicenter survey.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1959, doi. 10.1007/s10147-024-02614-z
    By:
    • Ono, Masanori;
    • Takai, Yasushi;
    • Harada, Miyuki;
    • Horie, Akihito;
    • Dai, Yidan;
    • Kikuchi, Eiji;
    • Miyachi, Mitsuru;
    • Yamamoto, Tetsuya;
    • Fujii, Nobuharu;
    • Kajiyama, Hiroaki;
    • Manabe, Atsushi;
    • Yasuoka, Toshiaki;
    • Katsuragi, Shinji;
    • Mekaru, Keiko;
    • Maezawa, Tadashi;
    • Horage, Yuki;
    • Kataoka, Shinsuke;
    • Nakayama, Robert;
    • Nakajima, Takako Eguchi;
    • Kimura, Fuminori
    Publication type:
    Article
    44

    Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x
    By:
    • Yokomizo, Ayako;
    • Nakashima, Kazuhisa;
    • Iba, Arisa;
    • Okita, Kenji;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi
    Publication type:
    Article
    45

    Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
    By:
    • Hayashi, Toshinobu;
    • Yamamoto, Shun;
    • Miyata, Yoshiharu;
    • Takeda, Masayuki;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    46

    Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
    By:
    • Kobayashi, Masamitsu;
    • Kako, Jun;
    • Iba, Arisa;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    47

    2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
    By:
    • Iihara, Hirotoshi;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi;
    • Higashi, Takahiro;
    • Boku, Narikazu
    Publication type:
    Article
    48

    Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 235, doi. 10.1007/s10120-021-01237-x
    By:
    • Takahashi, Yoshikazu;
    • Sunakawa, Yu;
    • Inoue, Eisuke;
    • Kawabata, Ryohei;
    • Ishiguro, Atsushi;
    • Kito, Yosuke;
    • Akamaru, Yusuke;
    • Takahashi, Masazumi;
    • Yabusaki, Hiroshi;
    • Matsuyama, Jin;
    • Makiyama, Akitaka;
    • Tsuda, Masahiro;
    • Suzuki, Takahisa;
    • Yasui, Hisateru;
    • Matoba, Ryo;
    • Kawakami, Hisato;
    • Nakajima, Takako Eguchi;
    • Muro, Kei;
    • Ichikawa, Wataru;
    • Fujii, Masashi
    Publication type:
    Article
    49

    Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.

    Published in:
    2021
    By:
    • Fujitani, Kazumasa;
    • Shitara, Kohei;
    • Takashima, Atsuo;
    • Koeda, Keisuke;
    • Hara, Hiroki;
    • Nakayama, Norisuke;
    • Hironaka, Shuichi;
    • Nishikawa, Kazuhiro;
    • Kimura, Yutaka;
    • Amagai, Kenji;
    • Hosaka, Hisashi;
    • Komatsu, Yoshito;
    • Shimada, Ken;
    • Kawabata, Ryohei;
    • Ohdan, Hideki;
    • Kodera, Yasuhiro;
    • Nakamura, Masato;
    • Nakajima, Takako Eguchi;
    • Miyata, Yoshinori;
    • Moriwaki, Toshikazu
    Publication type:
    Correction Notice
    50

    Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.

    Published in:
    Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
    By:
    • Fujitani, Kazumasa;
    • Shitara, Kohei;
    • Takashima, Atsuo;
    • Koeda, Keisuke;
    • Hara, Hiroki;
    • Nakayama, Norisuke;
    • Hironaka, Shuichi;
    • Nishikawa, Kazuhiro;
    • Kimura, Yutaka;
    • Amagai, Kenji;
    • Hosaka, Hisashi;
    • Komatsu, Yoshito;
    • Shimada, Ken;
    • Kawabata, Ryohei;
    • Ohdan, Hideki;
    • Kodera, Yasuhiro;
    • Nakamura, Masato;
    • Nakajima, Takako Eguchi;
    • Miyata, Yoshinori;
    • Moriwaki, Toshikazu
    Publication type:
    Article